Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Macrophages in human disease
- APC pattern recognition receptors
- Macrophage receptors
- Macrophage interactions
- Paradigm of macrophage activation
- Differential activation of macrophage
- Monocyte recruitment
- Tissue macrophage heterogeneity
- Anti-CR3 MAB blocks resistance to listeria
- Listeria rocket
- Phagocytosis of apoptotic thymocyte
- Antibody-coated erythrocytes (EIgG)
- Zymosan phagocytosis
- Dynamic membrane flow within macrophages
- Phagosomal pH
- Activation model for NLRP3 inflammasome
- DNA sensing and type 1 interferon
- Strategies for pathogen entry
- Coiling phagocytosis: Legionella
- Toxoplasma gondii inhibits lysosomal fusion
- Lipid metabolism
- Atherosclerosis - a sterile form of inflammation
- Class A scavenger receptor
- SR-A binding screen: Method and profile
- SR-A & Neisseria meningitidis (NM)
- Meningococcal septicaemia
- MARCO - summary
- NM, IFN-γ and TLR4 affect MARCO’s level
- Receptor collaboration
- SR-A/MARCO limits TLR4 response in vivo
- Dectin-1 is a phagocytic receptor for zymosan
- Uptake of C. albicans by macrophages
- Collaborative signalling for cytokine production
- Immune responses mediated by dectin-1
- Antifungal agent and TLR combination therapy
- Inborn errors of metabolism
- Respiratory burst
- Inflammation
- M. tuberculosis, BCG & macrophage activation
- Early papers of George Mackaness
- Epithelioid transformation
- Mannose receptor (MR): Overview
- Alternative macrophage activation (IL4/IL13)
- Two-stage alternative activation
- Transglutaminase 2: A conserved marker
- Schistosome egg granuloma
- TGM2 expression in schistosome egg granuloma
- TGM2 is a conserved AAM marker
- Macrophage fusion
- Quantitation of Macrophage fusion
- Isolation of antibodies
- MGCs take up larger beads
- Cell fusion and macrophage differentiation
- Only MGC takes up and digests amyloid
- Macrophages and cancer
- Anti-CD47 - blocks “don’t eat me”
- Macrophages in immunity
- Thank you for listening
- Acknowledgement
Topics Covered
- Macrophages in human disease
- Macrophage receptors and interactions
- Differential activation of macrophage
- Tissue macrophage heterogeneity
- Macrophage fusion and differentiation
- Macrophages and cancer
- Regulation of macrophages
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Gordon, S. (2021, December 12). The mononuclear phagocyte system: tissue resident macrophages - activation and regulation [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/HTPX3392.Export Citation (RIS)
Publication History
Financial Disclosures
- Siamon Gordon recieves Honoraria from Verseau Therapeutics and Myeloid Therapeutics. He has recieveid royalties from Thermo Fisher Scientific, and is involved in Bio-Rad sales.
The mononuclear phagocyte system: tissue resident macrophages - activation and regulation
Published on December 12, 2021
68 min
Other Talks in the Series: The Immune System - Key Concepts and Questions
Transcript
Please wait while the transcript is being prepared...
0:00
I'm Siamon Gordon and I work at the Sir William Dunn School of Pathology in Oxford.
Welcome to my talk, this will be part two of
the mononuclear phagocyte system which deals with tissue
recruited macrophages activation and regulation and part
1 dealt with tissue resident macrophages and their distribution and functions.
0:24
I'd like to just describe broadly the role of macrophages in human diseases.
First of all, genetically there are
lysosomal storage diseases such as Gaucher's disease and others,
in which due to enzyme deficiencies for example a substrate accumulates,
or enzymes accumulate or they form,
they can't be degraded properly.
Metabolic diseases include atherosclerosis, diabetes,
inflammatory conditions will include the dust diseases,
pneumoconiosis, silicosis, asbestosis.
Infection, of course, is very important,
not only bacterial infections such as tuberculosis and legionnaires disease,
but also HIV infection and I'll deal with some of that later on.
Autoimmune diseases like rheumatoid arthritis features,
the macrophages play a very prominent role in cartilage and bone erosion.
Degenerative diseases in the nervous system for example,
Alzheimer's disease and in the lung,
emphysema are important fibrosis important aspects of tissue repair.
In neoplastic diseases, of course,
macrophage is an important part as
tumour-associated macrophages and cancer stroma and myeloma,
for example directly mesothelioma, the asbestos-induced disease.
They play a particularly important role in chronic inflammation although they
also contribute to acute inflammation together
with neutrophils platelets and other elements.
Hide